Bidisomide
Title: Bidisomide
CAS Registry Number: 116078-65-0
CAS Name: a-[2-[Acetyl(1-methylethyl)amino]ethyl]-a-(2-chlorophenyl)-1-piperidinebutanamide
Additional Names: (±)-a-(o-chlorophenyl)-a-[2-(N-isopropylacetamido)ethyl]-1-piperidinebutyramide
Manufacturers' Codes: SC-40230
Molecular Formula: C22H34ClN3O2
Molecular Weight: 407.98
Percent Composition: C 64.77%, H 8.40%, Cl 8.69%, N 10.30%, O 7.84%
Literature References: Sodium channel blocker. Prepn: B. N. Desai et al., EP 170901; eidem, US 4639524 (1986, 1987 both to Searle); eidem, J. Med. Chem. 31, 2158 (1988). Cardiovascular pharmacology: L. G. Frederick et al., Cardiovasc. Res. 23, 897 (1989). Electrophysiologic study: S. M. Garthwaite et al., Drug Dev. Res. 27, 329 (1992). Bioavailability and tolerability in humans: R. L. Page et al., Clin. Pharmacol. Ther. 51, 371 (1992). Clinical pharmacokinetics: C. S. Cook et al., Pharm. Res. 10, 1675 (1993).
Properties: Crystals from ethyl acetate, mp 140-141°.
Melting point: mp 140-141°
Therap-Cat: Antiarrhythmic (class I).
Keywords: Antiarrhythmic.

Others monographs:
SuxibuzoneEthylestrenolBenzilCyclexedrine
InulinSuplatast TosylatePhosphorylcholineLevetiracetam
AcridineNebularinePalladiumDibucaine
Tritolyl PhosphateStryker's ReagentHycanthonePotassium Triiodide
©2016 DrugLead US FDA&EMEA